Atrial Fibrillation and Kidney Disease
Introduction to the Relationship
- Atrial fibrillation can directly contribute to the development and progression of chronic kidney disease and kidney failure through a bidirectional relationship, as stated by the American College of Cardiology, where AF accelerates renal dysfunction independent of shared risk factors 1, 2
Mechanisms of Kidney Damage
- Hemodynamic instability due to atrial fibrillation reduces cardiac output by 15-20%, leading to decreased renal perfusion and chronic ischemic injury to the kidneys, according to the American College of Cardiology 1, 2
- The American College of Cardiology recommends considering the mechanisms by which AF causes kidney damage, including microembolization, which promotes formation of microthrombi that can embolize to the renal vasculature, causing subclinical infarcts and progressive nephron loss 1
Risk Factors and Amplification
- In older adults with underlying cardiovascular disease, hypertension, and diabetes, the risk of AF-induced kidney failure is substantially magnified, as noted by the American College of Cardiology and Circulation 1, 2
- The European Heart Journal suggests that hypertension with left ventricular hypertrophy increases left atrial pressure, worsening both AF burden and renal venous congestion 3
Clinical Evidence and Guidelines
- The American College of Cardiology states that the relationship between AF and kidney failure represents a causal pathway, with population studies demonstrating that baseline AF predicts new renal dysfunction and proteinuria during follow-up 1
- The American College of Cardiology and Circulation recommend aggressive monitoring of renal function in older adults with AF, cardiovascular disease, hypertension, and diabetes, including assessment of serum creatinine, estimated glomerular filtration rate, and urine albumin-to-creatinine ratio at baseline and at least annually 1, 2
- The 2023 ACC/AHA guidelines, as reported in Circulation, emphasize careful assessment of both stroke and bleeding risk in patients with AF and CKD, with particular attention to anticoagulant dosing adjustments as renal function declines 2